Publication
Nano‐in‐Micro POxylated Polyurea Dendrimers and Chitosan Dry Powder Formulations for Pulmonary Delivery
dc.contributor.author | Restani, Rita | |
dc.contributor.author | Silva, A. Sofia | |
dc.contributor.author | Pires, Rita | |
dc.contributor.author | Cabral, Renato | |
dc.contributor.author | Correia, Ilídio Joaquim Sobreira | |
dc.contributor.author | Casimiro, Teresa | |
dc.contributor.author | Bonifácio, Vasco | |
dc.contributor.author | Ricardo, Ana Aguiar | |
dc.date.accessioned | 2018-03-21T14:18:03Z | |
dc.date.available | 2018-03-21T14:18:03Z | |
dc.date.issued | 2016-08-03 | |
dc.description.abstract | Pulmonary administration offers excellent advantages over conventional drug delivery routes, including increasing therapeutics bioavailability, and avoiding long‐term safety issues. Formulations of nano‐in‐micro dry powders for lung delivery are engineered using (S)‐ibuprofen as a model drug. These biodegradable formulations comprise nanoparticles of drug‐loaded POxylated polyurea dendrimers coated with chitosan using supercritical‐fluid‐assisted spray drying. The formulations are characterized in terms of morphology, particle‐size distribution, in vitro aerodynamic particle pulmonary distribution, and glutathione‐S‐transferase assay. It is demonstrated that ibuprofen‐loaded nanoparticles can be successfully incorporated into microspheres with adequate aerodynamic properties, mass median aerodynamic diameter (1.86–3.83 μm), and fine particle fraction (28%–45%), for deposition into the deep lung. The (S)‐ibuprofen dry powder formulations show enhanced solubility, high swelling behavior and a sustained drug release at physiologic pH. Also, POxylated polyureas decrease the (S)‐ibuprofen toxic effect on cancer cellular growth. The 3‐(4,5‐dimethylthiazol‐2‐yl)‐5‐(3‐carboxymethoxyphenyl)‐2‐(4‐sulfophenyl)‐2H‐tetrazolium (MTS) assays show no significant cytotoxicity on the metabolic activity of human lung adenocarcinoma ephithelial (A549) cell line for the lowest concentration (1 × 10−3 m), even for longer periods of contact with the cells (up to 120 h), and in the normal human dermal fibroblasts cell line the toxic effect is also reduced. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Restani, R. B., Silva, A. S., Pires, R. F., Cabral, R., Correia, I. J., Casimiro, T., Bonifácio, V. D. B. e Aguiar‐Ricardo, A. (2016) “Nano‐in‐Micro POxylated Polyurea Dendrimers and Chitosan Dry Powder Formulations for Pulmonary Delivery.” Particle & Particle Systems Characterization, Vol.33 (11), pp.851-858 | pt_PT |
dc.identifier.doi | 10.1002/ppsc.201600123 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.6/4686 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Wiley | pt_PT |
dc.relation | Associated Laboratory for Green Chemistry - Clean Technologies and Processes | |
dc.relation | Smart porous particles for pulmonary drug and vaccine delivery | |
dc.relation.publisherversion | https://onlinelibrary.wiley.com/doi/abs/10.1002/ppsc.201600123 | pt_PT |
dc.subject | Ibuprofen | pt_PT |
dc.subject | Polyurea | pt_PT |
dc.subject | Dendrimers | pt_PT |
dc.subject | Chitosan | pt_PT |
dc.title | Nano‐in‐Micro POxylated Polyurea Dendrimers and Chitosan Dry Powder Formulations for Pulmonary Delivery | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.awardTitle | Associated Laboratory for Green Chemistry - Clean Technologies and Processes | |
oaire.awardTitle | Smart porous particles for pulmonary drug and vaccine delivery | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UID%2FQUI%2F50006%2F2013/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FEQU-EQU%2F116097%2F2009/PT | |
oaire.citation.endPage | 858 | pt_PT |
oaire.citation.startPage | 851 | pt_PT |
oaire.citation.title | Particle & Particle Systems Characterization | pt_PT |
oaire.citation.volume | 33 | pt_PT |
oaire.fundingStream | 6817 - DCRRNI ID | |
oaire.fundingStream | 3599-PPCDT | |
person.familyName | Matias da Silva | |
person.familyName | Cabral | |
person.familyName | Joaquim Sobreira Correia | |
person.familyName | Casimiro | |
person.familyName | Bonifácio | |
person.familyName | Aguiar-Ricardo | |
person.givenName | Ana Sofia | |
person.givenName | Renato | |
person.givenName | Ilídio | |
person.givenName | Teresa | |
person.givenName | Vasco Daniel Bigas | |
person.givenName | Ana | |
person.identifier | UMbJ1KMAAAAJ | |
person.identifier | bit.ly/google_scholar_bonifacio | |
person.identifier | 239073 | |
person.identifier.ciencia-id | 7A1A-FEC8-7940 | |
person.identifier.ciencia-id | F610-7373-DC81 | |
person.identifier.ciencia-id | C319-27F6-1C6B | |
person.identifier.ciencia-id | AE14-EB30-86A6 | |
person.identifier.ciencia-id | 2C1A-9947-19BA | |
person.identifier.orcid | 0000-0002-5388-1732 | |
person.identifier.orcid | 0000-0003-0762-5890 | |
person.identifier.orcid | 0000-0003-1613-9675 | |
person.identifier.orcid | 0000-0001-9405-6221 | |
person.identifier.orcid | 0000-0003-2349-8473 | |
person.identifier.orcid | 0000-0002-2193-1440 | |
person.identifier.rid | C-3286-2011 | |
person.identifier.scopus-author-id | 57195299500 | |
person.identifier.scopus-author-id | 7003557499 | |
person.identifier.scopus-author-id | 6602194100 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
rcaap.embargofct | Copyright cedido à editora no momento da publicação | pt_PT |
rcaap.rights | closedAccess | pt_PT |
rcaap.type | article | pt_PT |
relation.isAuthorOfPublication | d520a5a3-94a9-4b6d-ae60-4f7b1b2e4b71 | |
relation.isAuthorOfPublication | cfc59b3c-d855-4e2f-816d-bf02bd421fe2 | |
relation.isAuthorOfPublication | f2c3e779-34a2-4309-950a-80687664c6ad | |
relation.isAuthorOfPublication | 851fdb4e-afc8-44e5-895b-26beaf4f8234 | |
relation.isAuthorOfPublication | 25a08d6b-f1f6-43e2-b59c-eb82fad34ef8 | |
relation.isAuthorOfPublication | 11660e51-cb00-4f75-8ca1-274d0c47c590 | |
relation.isAuthorOfPublication.latestForDiscovery | 25a08d6b-f1f6-43e2-b59c-eb82fad34ef8 | |
relation.isProjectOfPublication | 53457c50-6387-4f82-94d3-7a4d2ba42964 | |
relation.isProjectOfPublication | 49b7bf99-eb69-4301-a72f-3f11286ea606 | |
relation.isProjectOfPublication.latestForDiscovery | 49b7bf99-eb69-4301-a72f-3f11286ea606 |